VEGFA and diabetic retinopathy: Matrine could inhibit the release of inflammatory factors, regulate VEGF (vascular endothelial growth factor) and angiopoietin-1, inhibit the proliferation of retinal microvascular endothelial cells, and reduce diabetic retinopathy (Zhang, 2019).